Redhawk Wealth Advisors, Inc.

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1535811 MINNEAPOLIS, MN

Position in HALO

as of Mar 31, 2026 · filed Apr 15, 2026 Compact

Position Value

$2,123,806

-$300,138 QoQ

Shares Held

32,861

-8.8% QoQ

Ownership

0.028%

of shares outstanding

% of Portfolio

0.64%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Redhawk Wealth Advisors, Inc. holds $2,756,987 across 5 Biotechnology names. HALO ranks #1 (77.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HALO	Halozyme Therapeutics, Inc. This page	32,861	$2,123,806
2	VRTX	Vertex Pharmaceuticals Inc / Ma	1,164	$519,772
3	TNYA	Tenaya Therapeutics, Inc.	65,350	$45,222
4	ATYR	aTYR PHARMA INC	49,150	$38,337
5	SGMOQ	Sangamo Therapeutics, Inc	119,400	$29,850

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,123,806	32,861	-8.8%	Shares	Sole	2026-04-15
2025-12-31	$2,423,944	36,017	-1.5%	Shares	Sole	2026-01-14
2025-09-30	$2,682,410	36,575	-2.3%	Shares	Sole	2025-10-09
2025-06-30	$1,946,536	37,419	+14.8%	Shares	Sole	2025-07-10
2025-03-31	$2,079,695	32,592	-14.3%	Shares	Sole	2025-04-15
2024-12-31	$1,818,453	38,035	+3.4%	Shares	Sole	2025-01-14
2024-09-30	$2,104,600	36,768	+3.2%	Shares	Sole	2024-10-11
2024-06-30	$1,864,696	35,613	—	Shares	Sole	2024-07-16
No filing history on record for this holder in this stock.